Jiaren Lyu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiaren Lyu has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Daofeng Chen
Fudan University
4 shared publications - Weilian Bao
Department of Pharmacology & the Key Laboratory of Smart Drug Delivery Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China; Department of Natural Medicine, School of Pharmacy, Fudan University, Shanghai, China
4 shared publications Hong Li
Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 201203, China
3 shared publicationsYang Liu
Department of Natural Medicine, School of Pharmacy, Fudan University, Shanghai 201203, China
3 shared publicationsGuize Feng
Department of Pharmacology & the Key Laboratory of Smart Drug Delivery Ministry of Education, School of Pharmacy, Fudan University, Shanghai 201210, China
2 shared publications- Xiaoyan Shen
Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 10 April 2025
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 15 (6) , 3073-3091
An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 inflammasome activation
- 10 April 2025
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 15 (6) , 3073-3091
Top Cited PapersOpen AccessAn anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 inflammasome activation
- Open Access
- 31 May 2024
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 14 (9) , 3964-3982
Aloe emodin promotes mucosal healing by modifying the differentiation fate of enteroendocrine cells via regulating cellular free fatty acid sensitivity
- 31 May 2024
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 14 (9) , 3964-3982
Open AccessAloe emodin promotes mucosal healing by modifying the differentiation fate of enteroendocrine cells via regulating cellular free fatty acid sensitivity
- 30 September 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 319 (Pt 2) , 117231
Rhei Radix et Rhizoma in Xuanbai-Chengqi decoction strengthens the intestinal barrier function and promotes lung barrier repair in preventing severe viral pneumonia induced by influenza A virus
- 30 September 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 319 (Pt 2) , 117231
Rhei Radix et Rhizoma in Xuanbai-Chengqi decoction strengthens the intestinal barrier function and promotes lung barrier repair in preventing severe viral pneumonia induced by influenza A virus
- Open Access
- 1 September 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (35) , eadh5016
Inhibiting sorting nexin 10 promotes mucosal healing through SREBP2-mediated stemness restoration of intestinal stem cells
Intestinal stem cell (ISC) is a promising therapeutic target for inflammatory bowel disease. Cholesterol availability is critical for ISC stemness. Low plasma cholesterol is a typical feature of Crohn’s disease (CD); however, its impact on mucosal healing remains unclear. Here, we identified an essential role of sorting nexin 10 (SNX10) in maintaining the stemness of ISCs. SNX10 expression in intestinal tissues positively correlates with the severity of human CD and mouse colitis. Conditional SNX10 knockout in intestinal epithelial cells or ISCs promotes intestinal mucosal repair by maintaining the ISC population associated with increased intracellular cholesterol synthesis. Disassociation of ERLIN2 with SCAP by SNX10 deletion enhances the activation of SREBP2, resulting in increased cholesterol biosynthesis. DC-SX029, a small-molecule inhibitor of SNX10, was used to verify the druggable potential of SNX10 for the treatment of patients with CD. Our study provides a strategy for mucosal healing through SREBP2-mediated stemness restoration of ISCs.
- 1 September 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (35) , eadh5016
Open AccessInhibiting sorting nexin 10 promotes mucosal healing through SREBP2-mediated stemness restoration of intestinal stem cells
Intestinal stem cell (ISC) is a promising therapeutic target for inflammatory bowel disease. Cholesterol availability is critical for ISC stemness. Low plasma cholesterol is a typical feature of Crohn’s disease (CD); however, its impact on mucosal healing remains unclear. Here, we identified an essential role of sorting nexin 10 (SNX10) in maintaining the stemness of ISCs. SNX10 expression in intestinal tissues positively correlates with the severity of human CD and mouse colitis. Conditional SNX10 knockout in intestinal epithelial cells or ISCs promotes intestinal mucosal repair by maintaining the ISC population associated with increased intracellular cholesterol synthesis. Disassociation of ERLIN2 with SCAP by SNX10 deletion enhances the activation of SREBP2, resulting in increased cholesterol biosynthesis. DC-SX029, a small-molecule inhibitor of SNX10, was used to verify the druggable potential of SNX10 for the treatment of patients with CD. Our study provides a strategy for mucosal healing through SREBP2-mediated stemness restoration of ISCs.